107
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Inhibitory Effect of Apolipoprotein A-I on Eosinophils in Allergic Rhinitis in vitro and in vivo

, , , , , & show all
Pages 89-96 | Received 24 Nov 2023, Accepted 08 Feb 2024, Published online: 13 Feb 2024

References

  • Ma T, Chen Y, Pang Y, et al. Prevalence and risk factors of allergic rhinitis and asthma in the southern edge of the plateau grassland region of northern China: a cross-sectional study. World Allergy Organ J. 2021;14(7):100537. doi:10.1016/j.waojou.2021.100537
  • Lee WWL, Puan KJ, Lee B, et al. Eosinophilic allergic rhinitis is strongly associated with the CD45RB(lo) subset of CD161(+) Th2 cells that secretes IL-2, IL-3, IL-4, IL-5, IL-9, and IL-13. Allergy. 2023;78(10):2794–2798. doi:10.1111/all.15846
  • Rasheed Z, Zedan K, Saif GB, et al. Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and immunoglobulin E. Clin Mol Allergy. 2018;16(1). doi:10.1186/s12948-018-0102-y
  • Wang WW, Zhu K, Yu HW, Pan YL. Interleukin-17A potentiates interleukin-13-induced eotaxin-3 production by human nasal epithelial cells from patients with allergic rhinitis. Int Forum Allergy Rhinol. 2019;9(11):1327–1333. doi:10.1002/alr.22382
  • Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol. 2022;19(3):168–179. doi:10.1038/s41569-021-00613-5
  • Kim KD, Lim HY, Lee HG, et al. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem Biophys Res Commun. 2005;338(2):1126–1136. doi:10.1016/j.bbrc.2005.10.065
  • Huang H, Li Z, Huang J, et al. Apolipoprotein A1 modulates teff/treg balance through scavenger receptor class B type I-dependent mechanisms in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2022;63(8):23. doi:10.1167/iovs.63.8.23
  • Chen RX, Jiang W-J, Liu S-C, et al. Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-κB pathway. Liver Int. 2023;43(1):234–248. doi:10.1111/liv.15448
  • Nandedkar SD, Weihrauch D, Xu H, et al. D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma. J Lipid Res. 2011;52(3):499–508. doi:10.1194/jlr.M012724
  • Wang W, Xu H, Shi Y, et al. Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung. J Lipid Res. 2010;51(9):2560–2570. doi:10.1194/jlr.M004549
  • Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi:10.1016/j.jaci.2017.03.050
  • Rye KA. High density lipoprotein structure, function, and metabolism: a new thematic series. J Lipid Res. 2013;54(8):2031–2033. doi:10.1194/jlr.E041350
  • Tani S, Nagao K, Hirayama A. Association of systemic inflammation with the serum apolipoprotein A-1 level: a cross-sectional pilot study. J Cardiol. 2016;68(2):168–177. doi:10.1016/j.jjcc.2015.08.016
  • Barochia AV, Gordon EM, Kaler M, et al. High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics. J Lipid Res. 2017;58(8):1713–1721. doi:10.1194/jlr.P077776
  • Wong CK, Ng SS, Lun SW, Cao J, Lam CW. Signalling mechanisms regulating the activation of human eosinophils by mast-cell-derived chymase: implications for mast cell-eosinophil interaction in allergic inflammation. Immunology. 2009;126(4):579–587. doi:10.1111/j.1365-2567.2008.02916.x
  • Yao X, Gordon EM, Figueroa DM, Barochia AV, Levine SJ. Emerging roles of apolipoprotein E and apolipoprotein A-I in the pathogenesis and treatment of lung disease. Am J Respir Cell Mol Biol. 2016;55(2):159–169. doi:10.1165/rcmb.2016-0060TR
  • Yao X, Vitek MP, Remaley AT, Levine SJ. Apolipoprotein mimetic peptides: a new approach for the treatment of asthma. Front Pharmacol. 2012;3:37. doi:10.3389/fphar.2012.00037
  • Yao X, Gordon EM, Barochia AV, Remaley AT, Levine SJ. The a’s have it: developing apolipoprotein A-I mimetic peptides into a novel treatment for asthma. Chest. 2016;150(2):283–288. doi:10.1016/j.chest.2016.05.035